Sertoli-Leydig tumors are rare tumors of the ovary, occurring in young women in the majority of cases. They constitute less than 0.5 % of all ovarian neoplasms and 1% of sex-cord tumors. Here, we report a case of a 26 year old multiparous woman presenting with abdominal lump, pain, secondary amenorrhea and virilizing signs and symptoms. A diagnosis of Sertoli-Leydig cell tumors of the ovary of intermediate differentiation with heterologous elements was given. Unilateral salpingo-oophorectomy followed by Bleomycin, Etoposide and Cisplatin combined chemotherapy was given. The patient was healthy and symptom-free at the 6 month follow-up.
INTRODUCTION

Sertoli-Leydig cell tumors of the ovary have been defined by World Health Organization (WHO) as tumors composed of variable proportions of Sertoli cells, Leydig cells and in the case of intermediate and poorly differentiated neoplasms,
primitive gonadal stroma and sometimes heterologous elements 1 . These are rare tumors accounting only for about 1% of sexcord-stromal tumors 2 and constitute < 0.5% of all the ovarian neoplasms; intermediate and poorly differentiated forms being the most common. SLCTs have been reported in females from 2-75 years of age with a mean age of 23-25 years in different studies 1 .75% of the cases present within 30 years. The majority of these tumors are benign, and most are localized unilaterally. Bilaterality is reported in only 2% cases 3 .
It has been reported that about one-third of the patients present with virilizing symptoms and signs like amenorrhoea, hirsutism, breast atrophy, clitoral hypertrophy and hoarseness. Some patients may have estrogenic manifestations like isosexual pseudo-precocity and menometrorrhagia. It has been seen that the androgenic manifestations are more common in the poorly differentiated tumors. 20% cases have been reported to have slightly raised AFP. However, 50% of these patients may have no endocrine symptomatology and instead have abdominal pain or swelling. Heterologous elements are seen in 20% of the SLCTs 4 .
CASE REPORT
A 26 year old married woman with 4 children, presented with secondary amenorrhea, pain abdomen and lower abdominal fullness for the last 2 years. On examination, hirsutism, hoarseness, breast atrophy and clitoromegaly were noted. Abdominal examination revealed a hard mass of about 20 weeks gestation size in the pelvic region. Ascites was absent. USG revealed a 12 × 8 cm cystic SOL with multiple septae in the left ovarian region. Chest X-ray and ECG were within normal limits. US guided FNAspiration yielded blood mixed mucoid material and microscopically seen to have poor cytological yield with only thick mucinous material. Estimation of androstenedione, by RadioImmunoAssay (RIA), showed a high value of 5.38 ng/ml (the normal value for adult female being 0.47-2.68 ng/ml.) The free testosterone level was 5.2 pg/ml. The normal level of free testosterone in cases of adult females usually ranges from 0.7 to 3.6 pg/ml. The estrogen and progesterone levels were within normal limits. A left sided salpingooophorectomy was done. Following the histopathology report, combination chemotherapy, usually with Bleomycin, Etoposide and Cisplatin (BEP) was started.
Pathologic findings: Gross examination showed a bilateral ovarian tumor of size 13 × 10 cm. The outer surface was congested. The cut section showed mainly cystic areas with one solid area. The cysts contained mucinous material. Multiple sections were given from representative areas. 
Inset shows Leydig cells at a higher magnification (H & E stain, 400x magnification)
Following the histopathology report, combination chemotherapy with Bleomycin, Etoposide and Cisplatin (BEP) was started. At 6 months follow-up, the virilizing symptoms and signs were found to have receded to a large extent. There was neither clinical nor sonographical evidence of recurrence and the sex hormone levels had returned to within normal range. . It is also interesting to note that the Sertoli and not the Leydig cells form the neoplastic component of these tumors 7 . Heterologous elements are seen in 20% of the SLCTs predominantly belonging to the moderately and poorly differentiated categories. The heterologous components may be in the form of mucinous glands, cartilage, bone, skeletal muscle, smooth muscle and fat 4 . However, smooth muscle element is described as rare occurrence 5 . Heterologous mesenchymal elements are usually found in the tumors that have sarcomatoid background. Several theories have been proposed to explain the histogenesis of heterologous elements in Sertoli-Leydig cell tumor. According to Young 
